Macrophage-Mediated Subversion of Anti-Tumour Immunity
Despite the incredible clinical benefits obtained by the use of immune checkpoint blockers (ICBs), resistance is still common for many types of cancer. Central for ICBs to work is activation and infiltration of cytotoxic CD8<sup>+</sup> T cells following tumour-antigen recognition. Howev...
| Autores principales: | , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
MDPI AG
2019-07-01
|
| Colección: | Cells |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2073-4409/8/7/747 |